Medibank Private Ltd
ASX:MPL

Watchlist Manager
Medibank Private Ltd Logo
Medibank Private Ltd
ASX:MPL
Watchlist
Price: 3.7 AUD -1.07% Market Closed
Market Cap: 10.2B AUD
Have any thoughts about
Medibank Private Ltd?
Write Note

Medibank Private Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medibank Private Ltd
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Medibank Private Ltd
ASX:MPL
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Generation Development Group Ltd
ASX:GDG
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
NobleOak Life Ltd
ASX:NOL
Accumulated Depreciation
-AU$1.8m
CAGR 3-Years
13%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
NIB Holdings Ltd
ASX:NHF
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medibank Private Ltd
Glance View

Market Cap
10.2B AUD
Industry
Insurance

Medibank Private Ltd., founded in 1976, has established itself as one of Australia’s leading health insurance providers, servicing millions of customers with a commitment to proactive healthcare and comprehensive policies. Initially created as a government initiative to offer affordable health coverage, the company transitioned to a publicly-listed entity in 2014. Medibank operates through two main divisions: Medibank for health insurance and ahm, which primarily targets budget-conscious consumers seeking value-driven options. The firm prides itself on its customer-centric approach, focusing on empowering members through digital health solutions and preventative care initiatives that emphasize wellness, not just illness. For investors, Medibank represents a unique opportunity within the healthcare sector, illustrating stable growth backed by a solid market presence and a loyal customer base. The company navigated the challenges posed by the pandemic adeptly, showcasing resilience as it adapted to changing consumer needs and regulatory landscapes. With an eye toward future profitability, Medibank continues to innovate, investing in technology and partnerships that enhance its service offerings. Its robust financial performance, characterized by consistent revenue generation and a solid dividend payout history, positions it as a reliable investment within the increasingly important health insurance landscape in Australia.

MPL Intrinsic Value
3.99 AUD
Undervaluation 7%
Intrinsic Value
Price

See Also

Back to Top